Glial response during cuprizone-induced de- and remyelination in the CNS: Lessons learned

Frontiers in Cellular Neuroscience

Volumn 8, Issue MAR, 2014, Pages

  Gudi, Viktoria ^a   Gingele, Stefan ^a   Skripuletz, Thomas ^a   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Astrocytes; Cuprizone mouse model; Demyelination; Growth factors; Microglia; Remyelination

Indexed keywords

EID: 84906316516     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00073     Document Type: Review

References (317)

1. Acs, P., and Komoly, S. (2012). Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. Ideggyogy. Sz. 65, 266-270.
2. Adamo, A. M., Paez, P. M., Escobar Cabrera, O. E., Wolfson, M., Franco, P. G., Pasquini, J. M., et al. (2006). Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin. Exp. Neurol. 198, 519-529. doi: 10.1016/j.expneurol.2005.12.027
3. Adamus, G., Machnicki, M., Amundson, D., Adlard, K., and Offner, H. (1997). Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis. J. Neurosci. Res. 50, 531-538. doi: 10.1002/(SICI)1097-4547(19971115)50:4%3C531::AID-JNR4%3E3.3.CO;2-8
4. Albert, M., Antel, J., Bruck, W., and Stadelmann, C. (2007). Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 17, 129-138. doi: 10.1111/j.1750-3639.2006.00043.x
5. Allan, S. M., Tyrrell, P. J., and Rothwell, N. J. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640. doi: 10.1038/nri1664
6. Ambrosini, E., Remoli, M. E., Giacomini, E., Rosicarelli, B., Serafini, B., Lande, R., et al. (2005). Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 64, 706-715. doi: 10.1097/01.jnen.0000173893.01929.fc
7. Ara, J., See, J., Mamontov, P., Hahn, A., Bannerman, P., Pleasure, D., et al. (2008). Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 86, 125-135. doi: 10.1002/jnr.21462
8. Armstrong, R. C., Le, T. Q., Flint, N. C., Vana, A. C., and Zhou, Y. X. (2006). Endogenous cell repair of chronic demyelination. J. Neuropathol. Exp. Neurol. 65, 245-256. doi: 10.1097/01.jnen.0000205142.08716.7e
9. Armstrong, R. C., Le, T. Q., Frost, E. E., Borke, R. C., and Vana, A. C. (2002). Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci. 22, 8574-8585.
10. Arnett, H. A., Fancy, S. P., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., et al. (2004). bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306, 2111-2115. doi: 10.1126/science.1103709
11. Arnett, H. A., Hellendall, R. P., Matsushima, G. K., Suzuki, K., Laubach, V. E., Sherman, P., et al. (2002). The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J. Immunol. 168, 427-433.
12. Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., and Ting, J. P. (2001). TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4, 1116-1122. doi: 10.1038/nn738
13. Arnett, H. A., Wang, Y., Matsushima, G. K., Suzuki, K., and Ting, J. P. (2003). Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J. Neurosci. 23, 9824-9832.
14. Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., et al. (2000). Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287, 860-864. doi: 10.1126/science.287.5454.860
15. Baerwald, K. D., and Popko, B. (1998). Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J. Neurosci. Res. 52, 230-239. doi: 10.1002/(SICI)1097-4547(19980415)52:2<230::AID-JNR11>3.0.CO;2-B
16. Bajetto, A., Bonavia, R., Barbero, S., and Schettini, G. (2002). Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 82, 1311-1329. doi: 10.1046/j.1471-4159.2002.01091.x
17. Bakker, D. A., and Ludwin, S. K. (1987). Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J. Neurol. Sci. 78, 125-137. doi: 10.1016/0022-510X(87)90055-4
18. Bansal, R., Kumar, M., Murray, K., Morrison, R. S., and Pfeiffer, S. E. (1996). Regulation of FGF receptors in the oligodendrocyte lineage. Mol. Cell. Neurosci. 7, 263-275. doi: 10.1006/mcne.1996.0020
19. Bansal, R., Lakhina, V., Remedios, R., and Tole, S. (2003). Expression of FGF receptors 1, 2, 3 in the embryonic and postnatal mouse brain compared with Pdgfralpha, Olig2 and Plp/dm20: implications for oligodendrocyte development. Dev. Neurosci. 25, 83-95. doi: 10.1159/000072258
20. Bansal, R., and Pfeiffer, S. E. (1997). FGF-2 converts mature oligodendrocytes to a novel phenotype. J. Neurosci. Res. 50, 215-228. doi: 10.1002/(SICI)1097-4547(19971015)50:2<215::AID-JNR10>3.0.CO;2-7
21. Barres, B. A., Burne, J. F., Holtmann, B., Thoenen, H., Sendtner, M., and Raff, M. C. (1996). Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol. Cell. Neurosci. 8, 146-156. doi: 10.1006/mcne.1996.0053
22. Barres, B. A., Hart, I. K., Coles, H. S., Burne, J. F., Voyvodic, J. T., Richardson, W. D., et al. (1992). Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70, 31-46. doi: 10.1016/0092-8674(92)90531-G
23. Barres, B. A., Schmid, R., Sendnter, M., and Raff, M. C. (1993). Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-295.
24. Beck, K. D., Powell-Braxton, L., Widmer, H. R., Valverde, J., and Hefti, F. (1995). Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14, 717-730. doi: 10.1016/0896-6273(95)90216-3
25. Benardais, K., Kotsiari, A., Skuljec, J., Koutsoudaki, P. N., Gudi, V., Singh, V., et al. (2013). Cuprizone [Bis(Cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox. Res. 24, 244-250. doi: 10.1007/s12640-013-9380-9
26. Besnard, F., Perraud, F., Sensenbrenner, M., and Labourdette, G. (1987). Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro. Neurosci. Lett. 73, 287-292. doi: 10.1016/0304-3940(87)90260-6
27. Biancotti, J. C., Kumar, S., and De Vellis, J. (2008). Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair. Neurochem. Res. 33, 2615-2628. doi: 10.1007/s11064-008-9792-8
28. Binder, M. D., Cate, H. S., Prieto, A. L., Kemper, D., Butzkueven, H., Gresle, M. M., et al. (2008). Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J. Neurosci. 28, 5195-5206. doi: 10.1523/JNEUROSCI.1180-08.2008
29. Blakemore, W. F. (1972). Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1, 413-426. doi: 10.1007/BF01102943
30. Blakemore, W. F. (1973a). Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J. Neurol. Sci. 20, 63-72. doi: 10.1016/0022-510X(73)90118-4
31. Blakemore, W. F. (1973b). Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J. Neurol. Sci. 20, 73-83. doi: 10.1016/0022-510X(73)90119-6
32. Blakemore, W. F. (1974). Remyelination of the superior cerebellar peduncle in old mice following demyelination induced by cuprizone. J. Neurol. Sci. 22, 121-126. doi: 10.1016/0022-510X(74)90059-8
33. Blakemore, W. F. (1981). Remyelination in the CNS. Prog. Clin. Biol. Res. 59A, 105-109.
34. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., and Springer, T. A. (1996). A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101-1109. doi: 10.1084/jem.184.3.1101
35. Block, M. L., Zecca, L., and Hong, J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69. doi: 10.1038/nrn2038
36. Bo, L., Vedeler, C. A., Nyland, H., Trapp, B. D., and Mork, S. J. (2003). Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult. Scler. 9, 323-331. doi: 10.1191/1352458503ms917oa
37. Boche, D., Perry, V. H., and Nicoll, J. A. (2013). Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 39, 3-18. doi: 10.1111/nan.12011
38. Bradl, M., and Lassmann, H. (2009). Progressive multiple sclerosis. Semin. Immunopathol. 31, 455-465. doi: 10.1007/s00281-009-0182-3
39. Bradl, M., and Lassmann, H. (2010). Oligodendrocytes: biology and pathology. Acta Neuropathol. 119, 37-53. doi: 10.1007/s00401-009-0601-5
40. Buschmann, J. P., Berger, K., Awad, H., Clarner, T., Beyer, C., and Kipp, M. (2012). Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J. Mol. Neurosci. 48, 66-76. doi: 10.1007/s12031-012-9773-x
41. Calderon, T. M., Eugenin, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S., et al. (2006). A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177, 27-39. doi: 10.1016/j.jneuroim.2006.05.003
42. Calver, A. R., Hall, A. C., Yu, W. P., Walsh, F. S., Heath, J. K., Betsholtz, C., et al. (1998). Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20, 869-882. doi: 10.1016/S0896-6273(00)80469-9
43. Cammer, W., Sacchi, R., and Sapirstein, V. (1985). Immunocytochemical localization of carbonic anhydrase in the spinal cords of normal and mutant (shiverer) adult mice with comparisons among fixation methods. J. Histochem. Cytochem. 33, 45-54. doi: 10.1177/33.1.3917467
44. Carlton, W. W. (1966). Response of mice to the chelating agents sodium diethyldithiocarbamate, alpha-benzoinoxime, and biscyclohexanone oxaldihydrazone. Toxicol. Appl. Pharmacol. 8, 512-521. doi: 10.1016/0041-008X(66)90062-7
45. Carlton, W. W. (1967). Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. Life Sci. 6, 11-19. doi: 10.1016/0024-3205(67)90356-6
46. Carlton, W. W. (1969). Spongiform encephalopathy induced in rats and guinea pigs by cuprizone. Exp. Mol. Pathol. 10, 274-287. doi: 10.1016/0014-4800(69)90057-4
47. Cassetta, L., Cassol, E., and Poli, G. (2011). Macrophage polarization in health and disease. ScientificWorldJournal 11, 2391-2402. doi: 10.1100/2011/213962
48. Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C., Rittling, S. R., Denhardt, D. T., et al. (2001). The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731-1735. doi: 10.1126/science.1062960
49. Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., and Peterson, P. K. (1992). Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741.
50. Charles, P., Reynolds, R., Seilhean, D., Rougon, G., Aigrot, M. S., Niezgoda, A., et al. (2002). Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 125, 1972-1979. doi: 10.1093/brain/awf216
51. Chhor, V., Le Charpentier, T., Lebon, S., Ore, M. V., Celador, I. L., Josserand, J., et al. (2013). Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav. Immun. 32, 70-85. doi: 10.1016/j.bbi.2013.02.005
52. Connor, J. R., and Menzies, S. L. (1996). Relationship of iron to oligodendrocytes and myelination. Glia 17, 83-93. doi: 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7
53. Constantinescu, C. S., Farooqi, N., O'brien, K., and Gran, B. (2011). Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164, 1079-1106. doi: 10.1111/j.1476-5381.2011.01302.x
54. Copelman, C. A., Cuzner, M. L., Groome, N., and Diemel, L. T. (2000). Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: increments in CNTF, FGF-2, IGF-I, and PDGF-AA mRNA are induced by antibody-mediated demyelination. Glia 30, 342-351. doi: 10.1002/(SICI)1098-1136(200006)30:4%3C342::AID-GLIA30%3E3.0.CO;2-8
55. Copray, J. C., Kust, B. M., Mantingh-Otter, I., and Boddeke, H. W. (2005). p75NTR independent oligodendrocyte death in cuprizone-induced demyelination in C57BL/6 mice. Neuropathol. Appl. Neurobiol. 31, 600-609. doi: 10.1111/j.1365-2990.2005.00656.x
56. Cross, A. H., Keeling, R. M., Goorha, S., San, M., Rodi, C., Wyatt, P. S., et al. (1996). Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71, 145-153. doi: 10.1016/S0165-5728(96)00147-6
57. Cross, A. K., and Woodroofe, M. N. (1999). Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro. J. Neurosci. Res. 55, 17-23. doi: 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J
58. Dasilva, A. G., and Yong, V. W. (2008). Expression and regulation of matrix metalloproteinase-12 in experimental autoimmune encephalomyelitis and by bone marrow derived macrophages in vitro. J. Neuroimmunol. 199, 24-34. doi: 10.1016/j.jneuroim.2008.04.034
59. Delaunoy, J. P., Hog, F., Devilliers, G., Bansart, M., Mandel, P., and Sensenbrenner, M. (1980). Developmental changes and localization of carbonic anhydrase in cerebral hemispheres of the rat and in rat glial cell cultures. Cell. Mol. Biol. Incl. Cyto Enzymol. 26, 235-240.
60. Denhardt, D. T., and Guo, X. (1993). Osteopontin: a protein with diverse functions. FASEB J. 7, 1475-1482.
61. Denhardt, D. T., and Noda, M. (1998). Osteopontin expression and function: role in bone remodeling. J. Cell. Biochem. Suppl. 30-31, 92-102. doi: 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A
62. Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., et al. (2013). A regenerative approach to the treatment of multiple sclerosis. Nature 502, 327-332. doi: 10.1038/nature12647
63. Diemel, L. T., Copelman, C. A., and Cuzner, M. L. (1998). Macrophages in CNS remyelination: friend or foe? Neurochem. Res. 23, 341-347. doi: 10.1023/A:1022405516630
64. Doan, V., Kleindienst, A. M., Mcmahon, E. J., Long, B. R., Matsushima, G. K., and Taylor, L. C. (2013). Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss. J. Neurosci. Res. 91, 363-373. doi: 10.1002/jnr.23174
65. Doucette, J. R., Jiao, R., and Nazarali, A. J. (2010). Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice. Cell. Mol. Neurobiol. 30, 607-629. doi: 10.1007/s10571-009-9486-z
66. Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S., and Husar, W. (1996). Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184, 1513-1518. doi: 10.1084/jem.184.4.1513
67. Drescher, K. M., and Sosnowska, D. (2008). Being a mouse in a man's world: what TMEV has taught us about human disease. Front. Biosci. 13, 3775-3785. doi: 10.2741/2966
68. Dziembowska, M., Tham, T. N., Lau, P., Vitry, S., Lazarini, F., and Dubois-Dalcq, M. (2005). A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50, 258-269. doi: 10.1002/glia.20170
69. Edwards, J. P., Zhang, X., Frauwirth, K. A., and Mosser, D. M. (2006). Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 80, 1298-1307. doi: 10.1189/jlb.0406249
70. Emery, B., Merson, T. D., Snell, C., Young, K. M., Ernst, M., and Kilpatrick, T. J. (2006). SOCS3 negatively regulates LIF signaling in neural precursor cells. Mol. Cell. Neurosci. 31, 739-747. doi: 10.1016/j.mcn.2006.01.005
71. Eswarakumar, V. P., Lax, I., and Schlessinger, J. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149. doi: 10.1016/j.cytogfr.2005.01.001
72. Eugster, H. P., Frei, K., Bachmann, R., Bluethmann, H., Lassmann, H., and Fontana, A. (1999). Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29, 626-632. doi: 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A
73. Fenyk-Melody, J. E., Garrison, A. E., Brunnert, S. R., Weidner, J. R., Shen, F., Shelton, B. A., et al. (1998). Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160, 2940-2946.
74. Figiel, I. (2008). Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol. Exp. (Wars) 68, 526-534.
75. Fortin, D., Rom, E., Sun, H., Yayon, A., and Bansal, R. (2005). Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J. Neurosci. 25, 7470-7479. doi: 10.1523/JNEUROSCI.2120-05.2005
76. Franklin, R. J., and Gallo, V. (2014). The translational biology of remyelination: past, present, and future. Glia. doi: 10.1002/glia.22622. [Epub ahead of print].
77. Franklin, R. J., and Hinks, G. L. (1999). Understanding CNS remyelination: clues from developmental and regeneration biology. J. Neurosci. Res. 58, 207-213. doi: 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1
78. Fruttiger, M., Calver, A. R., Kruger, W. H., Mudhar, H. S., Michalovich, D., Takakura, N., et al. (1996). PDGF mediates a neuron-astrocyte interaction in the developing retina. Neuron 17, 1117-1131. doi: 10.1016/S0896-6273(00)80244-5
79. Gao, X., Gillig, T. A., Ye, P., D'ercole, A. J., Matsushima, G. K., and Popko, B. (2000). Interferon-gamma protects against cuprizone-induced demyelination. Mol. Cell. Neurosci. 16, 338-349. doi: 10.1006/mcne.2000.0883
80. Gardner, J., and Ghorpade, A. (2003). Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74, 801-806. doi: 10.1002/jnr.10835
81. Ghandour, M. S., Vincendon, G., Gombos, G., Limozin, N., Filippi, D., Dalmasso, C., et al. (1980). Carbonic anhydrase and oligodendroglia in developing rat cerebellum: a biochemical and imunohistological study. Dev. Biol. 77, 73-83. doi: 10.1016/0012-1606(80)90457-1
82. Giaccia, A. J., and Kastan, M. B. (1998). The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983. doi: 10.1101/gad.12.19.2973
83. Giachelli, C. M., Lombardi, D., Johnson, R. J., Murry, C. E., and Almeida, M. (1998). Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 152, 353-358.
84. Ginhoux, F., Lim, S., Hoeffel, G., Low, D., and Huber, T. (2013). Origin and differentiation of microglia. Front. Cell. Neurosci. 7:45. doi: 10.3389/fncel.2013.00045
85. Giulian, D., Baker, T. J., Shih, L. C., and Lachman, L. B. (1986). Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164, 594-604. doi: 10.1084/jem.164.2.594
86. Giulian, D., and Lachman, L. B. (1985). Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228, 497-499. doi: 10.1126/science.3872478
87. Giulian, D., Woodward, J., Young, D. G., Krebs, J. F., and Lachman, L. B. (1988). Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8, 2485-2490.
88. Goddard, D. R., Berry, M., and Butt, A. M. (1999). In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J. Neurosci. Res. 57, 74-85. doi: 10.1002/(SICI)1097-4547(19990701)57:1<74::AID-JNR8>3.0.CO;2-O
89. Goddard, D. R., Berry, M., Kirvell, S. L., and Butt, A. M. (2001). Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol. Cell. Neurosci. 18, 557-569. doi: 10.1006/mcne.2001.1025
90. Gold, R., Hartung, H. P., and Toyka, K. V. (2000). Animal models for autoimmune demyelinating disorders of the nervous system. Mol. Med. Today 6, 88-91. doi: 10.1016/S1357-4310(99)01639-1
91. Gold, R., Linington, C., and Lassmann, H. (2006). Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953-1971. doi: 10.1093/brain/awl075
92. Goldschmidt, T., Antel, J., Konig, F. B., Bruck, W., and Kuhlmann, T. (2009). Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72, 1914-1921. doi: 10.1212/WNL.0b013e3181a8260a
93. Gordon, S. (2003). Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35. doi: 10.1038/nri978
94. Grell, M. (1995). Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J. Inflamm. 47, 8-17.
95. Grinspan, J. B., Edell, E., Carpio, D. F., Beesley, J. S., Lavy, L., Pleasure, D., et al. (2000). Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte lineage. J. Neurobiol. 43, 1-17. doi: 10.1002/(SICI)1097-4695(200004)43:1%3C1::AID-NEU1%3E3.3.CO;2-S
96. Gudi, V., Moharregh-Khiabani, D., Skripuletz, T., Koutsoudaki, P. N., Kotsiari, A., Skuljec, J., et al. (2009). Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res. 1283, 127-138. doi: 10.1016/j.brainres.2009.06.005
97. Gudi, V., Skuljec, J., Yildiz, O., Frichert, K., Skripuletz, T., Moharregh-Khiabani, D., et al. (2011). Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS ONE 6:e22623. doi: 10.1371/journal.pone.0022623
98. Hagemeier, K., Bruck, W., and Kuhlmann, T. (2012). Multiple sclerosis-remyelination failure as a cause of disease progression. Histol. Histopathol. 27, 277-287.
99. Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394. doi: 10.1038/nn1997
100. Harry, G. J., and Kraft, A. D. (2012). Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology 33, 191-206. doi: 10.1016/j.neuro.2012.01.012
101. Hart, I. K., Richardson, W. D., Heldin, C. H., Westermark, B., and Raff, M. C. (1989). PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development 105, 595-603.
102. Hayashi, M., Luo, Y., Laning, J., Strieter, R. M., and Dorf, M. E. (1995). Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J. Neuroimmunol. 60, 143-150. doi: 10.1016/0165-5728(95)00064-9
103. Hemm, R. D., Carlton, W. W., and Welser, J. R. (1971). Ultrastructural changes of cuprizone encephalopathy in mice. Toxicol. Appl. Pharmacol. 18, 869-882. doi: 10.1016/0041-008X(71)90235-3
104. Hendriks, J. J., Slaets, H., Carmans, S., De Vries, H. E., Dijkstra, C. D., Stinissen, P., et al. (2008). Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J. Neuroimmunol. 204, 52-57. doi: 10.1016/j.jneuroim.2008.07.015
105. Hesse, A., Wagner, M., Held, J., Bruck, W., Salinas-Riester, G., Hao, Z., et al. (2010). In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol. Dis. 37, 362-369. doi: 10.1016/j.nbd.2009.10.016
106. Hibbits, N., Yoshino, J., Le, T. Q., and Armstrong, R. C. (2012). Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 4, 393-408. doi: 10.1042/AN20120062
107. Hinks, G. L., and Franklin, R. J. (1999). Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol. Cell. Neurosci. 14, 153-168. doi: 10.1006/mcne.1999.0771
108. Hinks, G. L., and Franklin, R. J. (2000). Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol. Cell. Neurosci. 16, 542-556. doi: 10.1006/mcne.2000.0897
109. Hiremath, M. M., Chen, V. S., Suzuki, K., Ting, J. P., and Matsushima, G. K. (2008). MHC class II exacerbates demyelination in vivo independently of T cells. J. Neuroimmunol. 203, 23-32. doi: 10.1016/j.jneuroim.2008.06.034
110. Hiremath, M. M., Saito, Y., Knapp, G. W., Ting, J. P., Suzuki, K., and Matsushima, G. K. (1998). Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 92, 38-49. doi: 10.1016/S0165-5728(98)00168-4
111. Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., et al. (2000). Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290, 1768-1771. doi: 10.1126/science.290.5497.1768
112. Hoppel, C. L., and Tandler, B. (1973). Biochemical effects of cuprizone on mouse liver and heart mitochondria. Biochem. Pharmacol. 22, 2311-2318. doi: 10.1016/0006-2952(73)90012-9
113. Hovelmeyer, N., Hao, Z., Kranidioti, K., Kassiotis, G., Buch, T., Frommer, F., et al. (2005). Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 175, 5875-5884.
114. Huang, J. K., Fancy, S. P., Zhao, C., Rowitch, D. H., Ffrench-Constant, C., and Franklin, R. J. (2011). Myelin regeneration in multiple sclerosis: targeting endogenous stem cells. Neurotherapeutics 8, 650-658. doi: 10.1007/s13311-011-0065-x
115. Irvine, K. A., and Blakemore, W. F. (2006). Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 175, 69-76. doi: 10.1016/j.jneuroim.2006.03.002
116. Ishibashi, T., Lee, P. R., Baba, H., and Fields, R. D. (2009). Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve. J. Neurosci. Res. 87, 3343-3355. doi: 10.1002/jnr.22173
117. Johnson, E. S., and Ludwin, S. K. (1981). The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol. 53, 93-98. doi: 10.1007/BF00689988
118. Kadi, L., Selvaraju, R., De Lys, P., Proudfoot, A. E., Wells, T. N., and Boschert, U. (2006). Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J. Neuroimmunol. 174, 133-146. doi: 10.1016/j.jneuroim.2006.01.011
119. Kang, Z., Liu, L., Spangler, R., Spear, C., Wang, C., Gulen, M. F., et al. (2012). IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination. J. Neurosci. 32, 8284-8292. doi: 10.1523/JNEUROSCI.0841-12.2012
120. Karpus, W. J., Lukacs, N. W., Mcrae, B. L., Strieter, R. M., Kunkel, S. L., and Miller, S. D. (1995). An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155, 5003-5010.
121. Kassiotis, G., and Kollias, G. (2001). Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193, 427-434. doi: 10.1084/jem.193.4.427
122. Kennedy, K. J., Strieter, R. M., Kunkel, S. L., Lukacs, N. W., and Karpus, W. J. (1998). Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1. J. Neuroimmunol. 92, 98-108. doi: 10.1016/S0165-5728(98)00187-8
123. Kerr, B. J., and Patterson, P. H. (2004). Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp. Neurol. 188, 391-407. doi: 10.1016/j.expneurol.2004.04.012
124. Kesterson, J. W., and Carlton, W. W. (1971). Monoamine oxidase inhibition and the activity of other oxidative enzymes in the brains of mice fed cuprizone. Toxicol. Appl. Pharmacol. 20, 386-395. doi: 10.1016/0041-008X(71)90281-X
125. Kidd, D., Barkhof, F., Mcconnell, R., Algra, P. R., Allen, I. V., and Revesz, T. (1999). Cortical lesions in multiple sclerosis. Brain 122(pt 1), 17-26. doi: 10.1093/brain/122.1.17
126. Kierdorf, K., and Prinz, M. (2013). Factors regulating microglia activation. Front. Cell. Neurosci. 7:44. doi: 10.3389/fncel.2013.00044
127. Kieseier, B. C., Seifert, T., Giovannoni, G., and Hartung, H. P. (1999). Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology 53, 20-25. doi: 10.1212/WNL.53.1.20
128. Kimberlin, R. H., Collis, S. C., and Walker, C. A. (1976). Profiles of brain glycosidase activity in cuprizone-fed Syrian hamsters and in scrapie-affected mice, rats, Chinese hamsters and Syrian hamsters. J. Comp. Pathol. 86, 135-142. doi: 10.1016/0021-9975(76)90038-4
129. Kipp, M., Clarner, T., Dang, J., Copray, S., and Beyer, C. (2009). The cuprizone animal model: new insights into an old story. Acta Neuropathol. 118, 723-736. doi: 10.1007/s00401-009-0591-3
130. Kipp, M., Clarner, T., Gingele, S., Pott, F., Amor, S., Van Der Valk, P., et al. (2011a). Brain lipid binding protein (FABP7) as modulator of astrocyte function. Physiol. Res. 60(Suppl. 1), S49-S60.
131. Kipp, M., Gingele, S., Pott, F., Clarner, T., Van Der Valk, P., Denecke, B., et al. (2011b). BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions. Brain Behav. Immun. 25, 1554-1568. doi: 10.1016/j.bbi.2011.05.003
132. Klein, R. S., and Rubin, J. B. (2004). Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. Trends Immunol. 25, 306-314. doi: 10.1016/j.it.2004.04.002
133. Komoly, S. (2005). Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Ideggyogy. Sz. 58, 40-43.
134. Komoly, S., Hudson, L. D., Webster, H. D., and Bondy, C. A. (1992). Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc. Natl. Acad. Sci. U.S.A. 89, 1894-1898. doi: 10.1073/pnas.89.5.1894
135. Komoly, S., Jeyasingham, M. D., Pratt, O. E., and Lantos, P. L. (1987). Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination. J. Neurol. Sci. 79, 141-148. doi: 10.1016/0022-510X(87)90268-1
136. Kondo, A., Nakano, T., and Suzuki, K. (1987). Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res. 425, 186-190. doi: 10.1016/0006-8993(87)90499-9
137. Kondo, T., and Raff, M. C. (2004). A role for Noggin in the development of oligodendrocyte precursor cells. Dev. Biol. 267, 242-251. doi: 10.1016/j.ydbio.2003.11.013
138. Kotter, M. R., Li, W. W., Zhao, C., and Franklin, R. J. (2006). Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 26, 328-332. doi: 10.1523/JNEUROSCI.2615-05.2006
139. Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., and Franklin, R. J. (2001). Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35, 204-212. doi: 10.1002/glia.1085
140. Kotter, M. R., Zhao, C., Van Rooijen, N., and Franklin, R. J. (2005). Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 18, 166-175. doi: 10.1016/j.nbd.2004.09.019
141. Koutsoudaki, P. N., Hildebrandt, H., Gudi, V., Skripuletz, T., Skuljec, J., and Stangel, M. (2010). Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV. Neuroscience 171, 235-244. doi: 10.1016/j.neuroscience.2010.08.070
142. Koutsoudaki, P. N., Skripuletz, T., Gudi, V., Moharregh-Khiabani, D., Hildebrandt, H., Trebst, C., et al. (2009). Demyelination of the hippocampus is prominent in the cuprizone model. Neurosci. Lett. 451, 83-88. doi: 10.1016/j.neulet.2008.11.058
143. Kuhlmann, T., Lucchinetti, C., Zettl, U. K., Bitsch, A., Lassmann, H., and Bruck, W. (1999). Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia 28, 34-39. doi: 10.1002/(SICI)1098-1136(199910)28:1<34::AID-GLIA4>3.0.CO;2-8
144. Kury, P., Zickler, P., Stoll, G., Hartung, H. P., and Jander, S. (2005). Osteopontin, a macrophage-derived matricellular glycoprotein, inhibits axon outgrowth. FASEB J. 19, 398-400. doi: 10.1096/fj.04-1777fje
145. Lai, C., and Lemke, G. (1991). An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6, 691-704. doi: 10.1016/0896-6273(91)90167-X
146. Lane, T. E., and Hosking, M. P. (2010). The pathogenesis of murine coronavirus infection of the central nervous system. Crit. Rev. Immunol. 30, 119-130. doi: 10.1615/CritRevImmunol.v30.i2.20
147. Larsen, P. H., and Yong, V. W. (2004). The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. J. Neurosci. 24, 7597-7603. doi: 10.1523/JNEUROSCI.2092-04.2004
148. Lassmann, H., Bruck, W., and Lucchinetti, C. F. (2007). The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17, 210-218. doi: 10.1111/j.1750-3639.2007.00064.x
149. Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170. doi: 10.1016/0306-4522(90)90229-W
150. Lazarini, F., Tham, T. N., Casanova, P., Arenzana-Seisdedos, F., and Dubois-Dalcq, M. (2003). Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42, 139-148. doi: 10.1002/glia.10139
151. Le, Y., Zhou, Y., Iribarren, P., and Wang, J. (2004). Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell. Mol. Immunol. 1, 95-104.
152. Lee, S. C., Dickson, D. W., and Brosnan, C. F. (1995). Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav. Immun. 9, 345-354. doi: 10.1006/brbi.1995.1032
153. Lehmann, H. C., Kohne, A., Bernal, F., Jangouk, P., Meyer Zu Horste, G., Dehmel, T., et al. (2009). Matrix metalloproteinase-2 is involved in myelination of dorsal root ganglia neurons. Glia 57, 479-489. doi: 10.1002/glia.20774
154. Li, J., Ghiani, C. A., Kim, J. Y., Liu, A., Sandoval, J., Devellis, J., et al. (2008). Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination. J. Neurosci. 28, 6118-6127. doi: 10.1523/JNEUROSCI.0184-08.2008
155. Li, M., and Ransohoff, R. M. (2008). Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 84, 116-131. doi: 10.1016/j.pneurobio.2007.11.003
156. Ligon, K. L., Fancy, S. P., Franklin, R. J., and Rowitch, D. H. (2006). Olig gene function in CNS development and disease. Glia 54, 1-10. doi: 10.1002/glia.20273
157. Lin, W., Kemper, A., Dupree, J. L., Harding, H. P., Ron, D., and Popko, B. (2006). Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129, 1306-1318. doi: 10.1093/brain/awl044
158. Linares, D., Taconis, M., Mana, P., Correcha, M., Fordham, S., Staykova, M., et al. (2006). Neuronal nitric oxide synthase plays a key role in CNS demyelination. J. Neurosci. 26, 12672-12681. doi: 10.1523/JNEUROSCI.0294-06.2006
159. Lindberg, R. L., De Groot, C. J., Montagne, L., Freitag, P., Van Der Valk, P., Kappos, L., et al. (2001). The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124, 1743-1753. doi: 10.1093/brain/124.9.1743
160. Lindner, M., Fokuhl, J., Linsmeier, F., Trebst, C., and Stangel, M. (2009). Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neurosci. Lett. 453, 120-125. doi: 10.1016/j.neulet.2009.02.004
161. Liu, L., Belkadi, A., Darnall, L., Hu, T., Drescher, C., Cotleur, A. C., et al. (2010). CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat. Neurosci. 13, 319-326. doi: 10.1038/nn.2491
162. Locksley, R. M., Killeen, N., and Lenardo, M. J. (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501. doi: 10.1016/S0092-8674(01)00237-9
163. Louis, J. C., Magal, E., Takayama, S., and Varon, S. (1993). CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259, 689-692. doi: 10.1126/science.8430320
164. Love, S. (1988). Cuprizone neurotoxicity in the rat: morphologic observations. J. Neurol. Sci. 84, 223-237. doi: 10.1016/0022-510X(88)90127-X
165. Lu, Q. R., Cai, L., Rowitch, D., Cepko, C. L., and Stiles, C. D. (2001). Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex. Nat. Neurosci. 4, 973-974. doi: 10.1038/nn718
166. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H. (2000). Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707-717. doi: 10.1002/1531-8249(200006)47:6%3C707::AID-ANA3%3E3.0.CO;2-Q
167. Lucchinetti, C. F., Bruck, W., Rodriguez, M., and Lassmann, H. (1996). Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6, 259-274. doi: 10.1111/j.1750-3639.1996.tb00854.x
168. Lucchinetti, C. F., Noseworthy, J. H., and Rodriguez, M. (1997). Promotion of endogenous remyelination in multiple sclerosis. Mult. Scler. 3, 71-75. doi: 10.1177/135245859700300202
169. Ludwin, S. K. (1978). Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab. Invest. 39, 597-612.
170. Ludwin, S. K. (1980). Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. Lab. Invest. 43, 382-387.
171. Mabie, P. C., Mehler, M. F., Marmur, R., Papavasiliou, A., Song, Q., and Kessler, J. A. (1997). Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. J. Neurosci. 17, 4112-4120.
172. Magnus, T., Schreiner, B., Korn, T., Jack, C., Guo, H., Antel, J., et al. (2005). Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J. Neurosci. 25, 2537-2546. doi: 10.1523/JNEUROSCI.4794-04.2005
173. Malemud, C. J. (2006). Matrix metalloproteinases (MMPs) in health and disease: an overview. Front. Biosci. 11, 1696-1701. doi: 10.2741/1915
174. Mana, P., Linares, D., Fordham, S., Staykova, M., and Willenborg, D. (2006). Deleterious role of IFNgamma in a toxic model of central nervous system demyelination. Am. J. Pathol. 168, 1464-1473. doi: 10.2353/ajpath.2006.050799
175. Marmur, R., Kessler, J. A., Zhu, G., Gokhan, S., and Mehler, M. F. (1998). Differentiation of oligodendroglial progenitors derived from cortical multipotent cells requires extrinsic signals including activation of gp130/LIFbeta receptors. J. Neurosci. 18, 9800-9811.
176. Marriott, M. P., Emery, B., Cate, H. S., Binder, M. D., Kemper, D., Wu, Q., et al. (2008). Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair. Glia 56, 686-698. doi: 10.1002/glia.20646
177. Martinez, F. O., Sica, A., Mantovani, A., and Locati, M. (2008). Macrophage activation and polarization. Front. Biosci. 13, 453-461. doi: 10.2741/2692
178. Mason, J. L., Jones, J. J., Taniike, M., Morell, P., Suzuki, K., and Matsushima, G. K. (2000a). Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J. Neurosci. Res. 61, 251-262. doi: 10.1002/1097-4547(20000801)61:3%3C251::AID-JNR3%3E3.0.CO;2-W
179. Mason, J. L., Suzuki, K., Chaplin, D. D., and Matsushima, G. K. (2001). Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21, 7046-7052.
180. Mason, J. L., Toews, A., Hostettler, J. D., Morell, P., Suzuki, K., Goldman, J. E., et al. (2004). Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am. J. Pathol. 164, 1673-1682. doi: 10.1016/S0002-9440(10)63726-1
181. Mason, J. L., Xuan, S., Dragatsis, I., Efstratiadis, A., and Goldman, J. E. (2003). Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J. Neurosci. 23, 7710-7718.
182. Mason, J. L., Ye, P., Suzuki, K., D'ercole, A. J., and Matsushima, G. K. (2000b). Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20, 5703-5708.
183. Matsushima, G. K., and Morell, P. (2001). The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107-116. doi: 10.1111/j.1750-3639.2001.tb00385.x
184. Mayer, M., Bhakoo, K., and Noble, M. (1994). Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120, 143-153.
185. Maysami, S., Nguyen, D., Zobel, F., Pitz, C., Heine, S., Hopfner, M., et al. (2006). Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12. Neuroreport 17, 1187-1190. doi: 10.1097/01.wnr.0000227985.92551.9a
186. Mazzali, M., Kipari, T., Ophascharoensuk, V., Wesson, J. A., Johnson, R., and Hughes, J. (2002). Osteopontin-a molecule for all seasons. QJM 95, 3-13. doi: 10.1093/qjmed/95.1.3
187. McCawley, L. J., and Matrisian, L. M. (2001). Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534-540. doi: 10.1016/S0955-0674(00)00248-9
188. McMahon, E. J., Cook, D. N., Suzuki, K., and Matsushima, G. K. (2001). Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier. J. Immunol. 167, 2964-2971.
189. McMahon, E. J., Suzuki, K., and Matsushima, G. K. (2002). Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J. Neuroimmunol. 130, 32-45. doi: 10.1016/S0165-5728(02)00205-9
190. McTigue, D. M., and Tripathi, R. B. (2008). The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 107, 1-19. doi: 10.1111/j.1471-4159.2008.05570.x
191. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., and Lane, T. E. (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
192. Merson, T. D., Binder, M. D., and Kilpatrick, T. J. (2010). Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. Neuromolecular Med. 12, 99-132. doi: 10.1007/s12017-010-8112-z
193. Messersmith, D. J., Murtie, J. C., Le, T. Q., Frost, E. E., and Armstrong, R. C. (2000). Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 62, 241-256. doi: 10.1002/1097-4547(20001015)62:2%3C241::AID-JNR9%3E3.0.CO;2-D
194. Mi, S., Miller, R. H., Lee, X., Scott, M. L., Shulag-Morskaya, S., Shao, Z., et al. (2005). LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 8, 745-751. doi: 10.1038/nn1460
195. Mi, S., Miller, R. H., Tang, W., Lee, X., Hu, B., Wu, W., et al. (2009). Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 65, 304-315. doi: 10.1002/ana.21581
196. Miller, R. H., and Mi, S. (2007). Dissecting demyelination. Nat. Neurosci. 10, 1351-1354. doi: 10.1038/nn1995
197. Moharregh-Khiabani, D., Blank, A., Skripuletz, T., Miller, E., Kotsiari, A., Gudi, V., et al. (2010). Effects of fumaric acids on cuprizone induced central nervous system de-and remyelination in the mouse. PLoS ONE 5:e11769. doi: 10.1371/journal.pone.0011769
198. Moore, C. S., Abdullah, S. L., Brown, A., Arulpragasam, A., and Crocker, S. J. (2011). How factors secreted from astrocytes impact myelin repair. J. Neurosci. Res. 89, 13-21. doi: 10.1002/jnr.22482
199. Morell, P., Barrett, C. V., Mason, J. L., Toews, A. D., Hostettler, J. D., Knapp, G. W., et al. (1998). Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol. Cell. Neurosci. 12, 220-227. doi: 10.1006/mcne.1998.0715
200. Mozell, R. L., and Mcmorris, F. A. (1991). Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J. Neurosci. Res. 30, 382-390. doi: 10.1002/jnr.490300214
201. Murphy, G. M. Jr. Jia, X. C., Song, Y., Ong, E., Shrivastava, R., Bocchini, V., et al. (1995). Macrophage inflammatory protein 1-alpha mRNA expression in an immortalized microglial cell line and cortical astrocyte cultures. J. Neurosci. Res. 40, 755-763. doi: 10.1002/jnr.490400607
202. Murry, C. E., Giachelli, C. M., Schwartz, S. M., and Vracko, R. (1994). Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145, 1450-1462.
203. Murtie, J. C., Zhou, Y. X., Le, T. Q., and Armstrong, R. C. (2005a). In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice. Glia 49, 542-554. doi: 10.1002/glia.20142
204. Murtie, J. C., Zhou, Y. X., Le, T. Q., Vana, A. C., and Armstrong, R. C. (2005b). PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol. Dis. 19, 171-182. doi: 10.1016/j.nbd.2004.12.006
205. Nair, A., Frederick, T. J., and Miller, S. D. (2008). Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65, 2702-2720. doi: 10.1007/s00018-008-8059-5
206. Nishiyama, A., Yu, M., Drazba, J. A., and Tuohy, V. K. (1997). Normal and reactive NG2+ glial cells are distinct from resting and activated microglia. J. Neurosci. Res. 48, 299-312. doi: 10.1002/(SICI)1097-4547(19970515)48:4<299::AID-JNR2>3.0.CO;2-6
207. Noble, M., Murray, K., Stroobant, P., Waterfield, M. D., and Riddle, P. (1988). Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333, 560-562. doi: 10.1038/333560a0
208. Norkute, A., Hieble, A., Braun, A., Johann, S., Clarner, T., Baumgartner, W., et al. (2009). Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J. Neurosci. Res. 87, 1343-1355. doi: 10.1002/jnr.21946
209. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T., et al. (1995). Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62, 103-112. doi: 10.1016/0165-5728(95)00114-H
210. Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., et al. (2012). Identification of a microglia phenotype supportive of remyelination. Glia 60, 306-321. doi: 10.1002/glia.21266
211. Ortler, S., Leder, C., Mittelbronn, M., Zozulya, A. L., Knolle, P. A., Chen, L., et al. (2008). B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Eur. J. Immunol. 38, 1734-1744. doi: 10.1002/eji.200738071
212. Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H., Schousboe, A., Haydon, P. G., et al. (2012). Glial cells in (patho)physiology. J. Neurochem. 121, 4-27. doi: 10.1111/j.1471-4159.2012.07664.x
213. Pasquini, L. A., Calatayud, C. A., Bertone Una, A. L., Millet, V., Pasquini, J. M., and Soto, E. F. (2007). The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem. Res. 32, 279-292. doi: 10.1007/s11064-006-9165-0
214. Patani, R., Balaratnam, M., Vora, A., and Reynolds, R. (2007). Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 33, 277-287. doi: 10.1111/j.1365-2990.2007.00805.x
215. Patel, J. R., Mccandless, E. E., Dorsey, D., and Klein, R. S. (2010). CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. U.S.A. 107, 11062-11067. doi: 10.1073/pnas.1006301107
216. Patel, J. R., Williams, J. L., Muccigrosso, M. M., Liu, L., Sun, T., Rubin, J. B., et al. (2012). Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta Neuropathol. 124, 847-860. doi: 10.1007/s00401-012-1034-0
217. Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., et al. (2006). Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165-3172. doi: 10.1093/brain/awl217
218. Pattison, I. H., and Jebbett, J. N. (1971a). Clinical and histological observations on cuprizone toxicity and scrapie in mice. Res. Vet. Sci. 12, 378-380.
219. Pattison, I. H., and Jebbett, J. N. (1971b). Histopathological similarities between scrapie and cuprizone toxicity in mice. Nature 230, 115-117. doi: 10.1038/230115a0
220. Pekny, M., and Nilsson, M. (2005). Astrocyte activation and reactive gliosis. Glia 50, 427-434. doi: 10.1002/glia.20207
221. Peterson, R. E., and Bollier, M. E. (1955). Spectrophotometric determination of serum copper with biscyclohexanone oxaldihydrazone. Analyt. Chem. 27, 1195-1197. doi: 10.1021/ac60103a054
222. Plant, S. R., Arnett, H. A., and Ting, J. P. (2005). Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination. Glia 49, 1-14. doi: 10.1002/glia.20089
223. Plant, S. R., Iocca, H. A., Wang, Y., Thrash, J. C., O'connor, B. P., Arnett, H. A., et al. (2007). Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. J. Neurosci. 27, 7429-7437. doi: 10.1523/JNEUROSCI.1307-07.2007
224. Pott, F., Gingele, S., Clarner, T., Dang, J., Baumgartner, W., Beyer, C., et al. (2009). Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia. Brain Res. 1305, 137-149. doi: 10.1016/j.brainres.2009.09.084
225. Prineas, J. W., and Connell, F. (1979). Remyelination in multiple sclerosis. Ann. Neurol. 5, 22-31. doi: 10.1002/ana.410050105
226. Pringle, N., Collarini, E. J., Mosley, M. J., Heldin, C. H., Westermark, B., and Richardson, W. D. (1989). PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cells in the developing rat optic nerve. EMBO J. 8, 1049-1056.
227. Raff, M. C., Lillien, L. E., Richardson, W. D., Burne, J. F., and Noble, M. D. (1988). Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333, 562-565. doi: 10.1038/333562a0
228. Raman, D., Sobolik-Delmaire, T., and Richmond, A. (2011). Chemokines in health and disease. Exp. Cell Res. 317, 575-589. doi: 10.1016/j.yexcr.2011.01.005
229. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., et al. (1993). Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7, 592-600.
230. Ransohoff, R. M., and Perry, V. H. (2009). Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145. doi: 10.1146/annurev.immunol.021908.132528
231. Remington, L. T., Babcock, A. A., Zehntner, S. P., and Owens, T. (2007). Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 170, 1713-1724. doi: 10.2353/ajpath.2007.060783
232. Reuss, B., and Von Bohlen Und Halbach, O. (2003). Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313, 139-157. doi: 10.1007/s00441-003-0756-7
233. Rezaie, P., Trillo-Pazos, G., Everall, I. P., and Male, D. K. (2002). Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 37, 64-75. doi: 10.1002/glia.1128
234. Robinson, S., and Miller, R. H. (1999). Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev. Biol. 216, 359-368. doi: 10.1006/dbio.1999.9466
235. Rothwell, N. J., and Luheshi, G. N. (2000). Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618-625. doi: 10.1016/S0166-2236(00)01661-1
236. Sabo, J. K., Aumann, T. D., Kilpatrick, T. J., and Cate, H. S. (2013). Investigation of sequential growth factor delivery during cuprizone challenge in mice aimed to enhance oligodendrogliogenesis and myelin repair. PLoS ONE 8:e63415. doi: 10.1371/journal.pone.0063415
237. Sabo, J. K., Aumann, T. D., Merlo, D., Kilpatrick, T. J., and Cate, H. S. (2011). Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. J. Neurosci. 31, 4504-4510. doi: 10.1523/JNEUROSCI.5859-10.2011
238. Sahrbacher, U. C., Lechner, F., Eugster, H. P., Frei, K., Lassmann, H., and Fontana, A. (1998). Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28, 1332-1338. doi: 10.1002/(SICI)1521-4141(199804)28:04<1332::AID-IMMU1332>3.0.CO;2-G
239. Sairanen, T. R., Lindsberg, P. J., Brenner, M., and Siren, A. L. (1997). Global forebrain ischemia results in differential cellular expression of interleukin-1beta (IL-1beta) and its receptor at mRNA and protein level. J. Cereb. Blood Flow Metab. 17, 1107-1120. doi: 10.1097/00004647-199710000-00013
240. Schmidt, T., Awad, H., Slowik, A., Beyer, C., Kipp, M., and Clarner, T. (2013). Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum. J. Mol. Neurosci. 49, 80-88. doi: 10.1007/s12031-012-9896-0
241. Schwartz, M., Butovsky, O., Bruck, W., and Hanisch, U. K. (2006). Microglial phenotype: is the commitment reversible? Trends Neurosci. 29, 68-74. doi: 10.1016/j.tins.2005.12.005
242. Selenica, M. L., Alvarez, J. A., Nash, K. R., Lee, D. C., Cao, C., Lin, X., et al. (2013). Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain. J. Neuroinflammation 10:86. doi: 10.1186/1742-2094-10-86
243. Selmaj, K. W., and Raine, C. S. (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346. doi: 10.1002/ana.410230405
244. Selvaraju, R., Bernasconi, L., Losberger, C., Graber, P., Kadi, L., Avellana-Adalid, V., et al. (2004). Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol. Cell. Neurosci. 25, 707-721. doi: 10.1016/j.mcn.2003.12.014
245. Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., et al. (2007). Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204, 2899-2912. doi: 10.1084/jem.20071030
246. Setzu, A., Lathia, J. D., Zhao, C., Wells, K., Rao, M. S., Ffrench-Constant, C., et al. (2006). Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54, 297-303. doi: 10.1002/glia.20371
247. Shankar, S. L., O'guin, K., Cammer, M., Mcmorris, F. A., Stitt, T. N., Basch, R. S., et al. (2003). The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. J. Neurosci. 23, 4208-4218.
248. Shen, S., Sandoval, J., Swiss, V. A., Li, J., Dupree, J., Franklin, R. J., et al. (2008). Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat. Neurosci. 11, 1024-1034. doi: 10.1038/nn.2172
249. Shields, S. A., Gilson, J. M., Blakemore, W. F., and Franklin, R. J. (1999). Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 28, 77-83. doi: 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F
250. Sicotte, N. L., and Voskuhl, R. R. (2001). Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57, 1885-1888. doi: 10.1212/WNL.57.10.1885
251. Silvestroff, L., Bartucci, S., Pasquini, J., and Franco, P. (2012). Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination. Exp. Neurol. 235, 357-367. doi: 10.1016/j.expneurol.2012.02.018
252. Sim, F. J., Zhao, C., Penderis, J., and Franklin, R. J. (2002). The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci. 22, 2451-2459.
253. Skripuletz, T., Bussmann, J. H., Gudi, V., Koutsoudaki, P. N., Pul, R., Moharregh-Khiabani, D., et al. (2010a). Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol. 20, 301-312. doi: 10.1111/j.1750-3639.2009.00271.x
254. Skripuletz, T., Gudi, V., Hackstette, D., and Stangel, M. (2011a). De-and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol. Histopathol. 26, 1585-1597.
255. Skripuletz, T., Hackstette, D., Bauer, K., Gudi, V., Pul, R., Voss, E., et al. (2013). Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136, 147-167. doi: 10.1093/brain/aws262
256. Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., et al. (2008). Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 172, 1053-1061. doi: 10.2353/ajpath.2008.070850
257. Skripuletz, T., Miller, E., Grote, L., Gudi, V., Pul, R., Voss, E., et al. (2011b). Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system. Brain Behav. Immun. 25, 1592-1606. doi: 10.1016/j.bbi.2011.05.009
258. Skripuletz, T., Miller, E., Moharregh-Khiabani, D., Blank, A., Pul, R., Gudi, V., et al. (2010b). Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem. Res. 35, 1422-1433. doi: 10.1007/s11064-010-0202-7
259. Skuljec, J., Gudi, V., Ulrich, R., Frichert, K., Yildiz, O., Pul, R., et al. (2011). Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter. J. Neuropathol. Exp. Neurol. 70, 758-769. doi: 10.1097/NEN.0b013e3182294fad
260. Sodek, J., Ganss, B., and Mckee, M. D. (2000). Osteopontin. Crit. Rev. Oral Biol. Med. 11, 279-303. doi: 10.1177/10454411000110030101
261. Soundarapandian, M. M., Selvaraj, V., Lo, U. G., Golub, M. S., Feldman, D. H., Pleasure, D. E., et al. (2011). Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination. Sci. Rep. 1:2. doi: 10.1038/srep00002
262. Stangel, M., and Hartung, H. P. (2002). Remyelinating strategies for the treatment of multiple sclerosis. Prog. Neurobiol. 68, 361-376. doi: 10.1016/S0301-0082(02)00105-3
263. Stankoff, B., Aigrot, M. S., Noel, F., Wattilliaux, A., Zalc, B., and Lubetzki, C. (2002). Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 22, 9221-9227.
264. Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292. doi: 10.1084/jem.176.1.287
265. Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., and Franklin, R. J. (2003). Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 13, 329-339. doi: 10.1111/j.1750-3639.2003.tb00032.x
266. Suckling, A. J., Pathak, S., Jagelman, S., and Webb, H. E. (1978). Virus-associated demyelination. A model using avirulent Semliki Forest virus infection of mice. J. Neurol. Sci. 39, 147-154. doi: 10.1016/0022-510X(78)90195-8
267. Sugiura, S., Lahav, R., Han, J., Kou, S. Y., Banner, L. R., De Pablo, F., et al. (2000). Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur. J. Neurosci. 12, 457-466. doi: 10.1046/j.1460-9568.2000.00922.x
268. Suvannavejh, G. C., Lee, H. O., Padilla, J., Dal Canto, M. C., Barrett, T. A., and Miller, S. D. (2000). Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cell. Immunol. 205, 24-33. doi: 10.1006/cimm.2000.1706
269. Suzuki, K. (1969). Giant hepatic mitochondria: production in mice fed with cuprizone. Science 163, 81-82. doi: 10.1126/science.163.3862.81
270. Suzuki, K., and Kikkawa, Y. (1969). Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone). Am. J. Pathol. 54, 307-325.
271. Takebayashi, H., Nabeshima, Y., Yoshida, S., Chisaka, O., and Ikenaka, K. (2002). The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr. Biol. 12, 1157-1163. doi: 10.1016/S0960-9822(02)00926-0
272. Talbott, J. F., Cao, Q., Bertram, J., Nkansah, M., Benton, R. L., Lavik, E., et al. (2007). CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo. Exp. Neurol. 204, 485-489. doi: 10.1016/j.expneurol.2006.12.013
273. Taylor, L. C., Gilmore, W., and Matsushima, G. K. (2009). SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination. Brain Pathol. 19, 467-479. doi: 10.1111/j.1750-3639.2008.00230.x
274. Taylor, L. C., Gilmore, W., Ting, J. P., and Matsushima, G. K. (2010). Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle. J. Neurosci. Res. 88, 391-402. doi: 10.1002/jnr.22215
275. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. (1999). TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53, 457-465. doi: 10.1212/WNL.53.3.457
276. Thorburne, S. K., and Juurlink, B. H. (1996). Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J. Neurochem. 67, 1014-1022. doi: 10.1046/j.1471-4159.1996.67031014.x
277. Torkildsen, O., Brunborg, L. A., Myhr, K. M., and Bo, L. (2008). The cuprizone model for demyelination. Acta Neurol. Scand. Suppl. 188, 72-76. doi: 10.1111/j.1600-0404.2008.01036.x
278. Tran, E. H., Hardin-Pouzet, H., Verge, G., and Owens, T. (1997). Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74, 121-129. doi: 10.1016/S0165-5728(96)00215-9
279. Tran, P. B., and Miller, R. J. (2003). Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 4, 444-455. doi: 10.1038/nrn1116
280. Tran, P. B., Ren, D., Veldhouse, T. J., and Miller, R. J. (2004). Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J. Neurosci. Res. 76, 20-34. doi: 10.1002/jnr.20001
281. Tsunoda, I., and Fujinami, R. S. (2010). Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J. Neuroimmune Pharmacol. 5, 355-369. doi: 10.1007/s11481-009-9179-x
282. Vana, A. C., Flint, N. C., Harwood, N. E., Le, T. Q., Fruttiger, M., and Armstrong, R. C. (2007). Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J. Neuropathol. Exp. Neurol. 66, 975-988. doi: 10.1097/NEN.0b013e3181587d46
283. Vandenabeele, P., Declercq, W., Beyaert, R., and Fiers, W. (1995). Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5, 392-399. doi: 10.1016/S0962-8924(00)89088-1
284. Van Heyningen, P., Calver, A. R., and Richardson, W. D. (2001). Control of progenitor cell number by mitogen supply and demand. Curr. Biol. 11, 232-241. doi: 10.1016/S0960-9822(01)00075-6
285. Van Horssen, J., Brink, B. P., De Vries, H. E., Van Der Valk, P., and Bo, L. (2007). The blood-brain barrier in cortical multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 66, 321-328. doi: 10.1097/nen.0b013e318040b2de
286. Van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., Von Blomberg, B. M., et al. (1996). Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47, 1531-1534. doi: 10.1212/WNL.47.6.1531
287. Vartanian, T., Li, Y., Zhao, M., and Stefansson, K. (1995). Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1, 732-743.
288. Vela, J. M., Molina-Holgado, E., Arevalo-Martin, A., Almazan, G., and Guaza, C. (2002). Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell. Neurosci. 20, 489-502. doi: 10.1006/mcne.2002.1127
289. Venturini, G. (1973). Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo. J. Neurochem. 21, 1147-1151. doi: 10.1111/j.1471-4159.1973.tb07569.x
290. Veto, S., Acs, P., Bauer, J., Lassmann, H., Berente, Z., Setalo, G., et al. (2010). Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. Brain 133, 822-834. doi: 10.1093/brain/awp337
291. Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., Van Der Valk, P., et al. (2013). Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J. Neuroinflammation 10:35. doi: 10.1186/1742-2094-10-35
292. Voss, E. V., Skuljec, J., Gudi, V., Skripuletz, T., Pul, R., Trebst, C., et al. (2012). Characterisation of microglia during de-and remyelination: can they create a repair promoting environment? Neurobiol. Dis. 45, 519-528. doi: 10.1016/j.nbd.2011.09.008
293. Wang, S., Sdrulla, A. D., Disibio, G., Bush, G., Nofziger, D., Hicks, C., et al. (1998a). Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21, 63-75. doi: 10.1016/S0896-6273(00)80515-2
294. Wang, S. Z., Dulin, J., Wu, H., Hurlock, E., Lee, S. E., Jansson, K., et al. (2006). An oligodendrocyte-specific zinc-finger transcription regulator cooperates with Olig2 to promote oligodendrocyte differentiation. Development 133, 3389-3398. doi: 10.1242/dev.02522
295. Wang, X., Louden, C., Yue, T. L., Ellison, J. A., Barone, F. C., Solleveld, H. A., et al. (1998b). Delayed expression of osteopontin after focal stroke in the rat. J. Neurosci. 18, 2075-2083.
296. Williams, A., Piaton, G., and Lubetzki, C. (2007). Astrocytes-friends or foes in multiple sclerosis? Glia 55, 1300-1312. doi: 10.1002/glia.20546
297. Wolswijk, G. (2002). Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125, 338-349. doi: 10.1093/brain/awf031
298. Woodruff, R. H., and Franklin, R. J. (1999). Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25, 216-228. doi: 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L
299. Woodruff, R. H., Fruttiger, M., Richardson, W. D., and Franklin, R. J. (2004). Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol. Cell. Neurosci. 25, 252-262. doi: 10.1016/j.mcn.2003.10.014
300. Wosik, K., Antel, J., Kuhlmann, T., Bruck, W., Massie, B., and Nalbantoglu, J. (2003). Oligodendrocyte injury in multiple sclerosis: a role for p53. J. Neurochem. 85, 635-644. doi: 10.1046/j.1471-4159.2003.01674.x
301. Yagami, T., Ueda, K., Asakura, K., Sakaeda, T., Nakazato, H., Kuroda, T., et al. (2002). Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis. Neuropharmacology 43, 1289-1296. doi: 10.1016/S0028-3908(02)00333-7
302. Yajima, K., and Suzuki, K. (1979). Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab. Invest. 41, 385-392.
303. Yao, D. L., Liu, X., Hudson, L. D., and Webster, H. D. (1995). Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 92, 6190-6194. doi: 10.1073/pnas.92.13.6190
304. Ye, P., Carson, J., and D'ercole, A. J. (1995). In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15, 7344-7356.
305. Ye, P., and D'Ercole, A. J. (1999). Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology 140, 3063-3072.
306. Ye, P., Li, L., Richards, R. G., Diaugustine, R. P., and D'Ercole, A. J. (2002). Myelination is altered in insulin-like growth factor-I null mutant mice. J. Neurosci. 22, 6041-6051.
307. Yong, V. W. (2005). Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931-944. doi: 10.1038/nrn1807
308. Zendedel, A., Beyer, C., and Kipp, M. (2013). Cuprizone-induced demyelination as a tool to study remyelination and axonal protection. J. Mol. Neurosci. 51, 567-572. doi: 10.1007/s12031-013-0026-4
309. Zhang, J., Kramer, E. G., Mahase, S., Dutta, D. J., Bonnamain, V., Argaw, A. T., et al. (2011). Targeting oligodendrocyte protection and remyelination in multiple sclerosis. Mt. Sinai J. Med. 78, 244-257. doi: 10.1002/msj.20244
310. Zhao, C., Fancy, S. P., Ffrench-Constant, C., and Franklin, R. J. (2008). Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiol. Dis. 31, 209-217. doi: 10.1016/j.nbd.2008.04.007
311. Zhao, C., Fancy, S. P., Magy, L., Urwin, J. E., and Franklin, R. J. (2005). Stem cells, progenitors and myelin repair. J. Anat. 207, 251-258. doi: 10.1111/j.1469-7580.2005.00456.x
312. Zhornitsky, S., Wee Yong, V., Koch, M. W., Mackie, A., Potvin, S., Patten, S. B., et al. (2013). Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair. CNS Neurosci. Ther. 19, 737-744. doi: 10.1111/cns.12154
313. Zhou, Q., and Anderson, D. J. (2002). The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109, 61-73. doi: 10.1016/S0092-8674(02)00677-3
314. Zhou, Q., Wang, S., and Anderson, D. J. (2000). Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25, 331-343. doi: 10.1016/S0896-6273(00)80898-3
315. Zhou, Y. X., Flint, N. C., Murtie, J. C., Le, T. Q., and Armstrong, R. C. (2006). Retroviral lineage analysis of fibroblast growth factor receptor signaling in FGF2 inhibition of oligodendrocyte progenitor differentiation. Glia 54, 578-590. doi: 10.1002/glia.20410
316. Zhou, Y. X., Pannu, R., Le, T. Q., and Armstrong, R. C. (2012). Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination. Neurobiol. Dis. 45, 196-205. doi: 10.1016/j.nbd.2011.08.004
317. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I., and Littman, D. R. (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599. doi: 10.1038/31269